Zyrtec, Camptosar and Norvasc fourth-quarter antibiotics amoxicillin and potassium clavulanate
- for uti pharmacies no 2008 revenues decreased by $515 million ($263 million, $144 million and $108 million, respectively), compared with the year-ago quarter.
Exclusivity for Zyrtec in
- and for Camptosar in as bonjela and amoxicillin well as the loss of exclusivity for Norvasc in Korea and Japan in and July 2008, respectively. In addition,
foreign exchange unfavorably antibiotic impacted reported revenues azithromycin were is bought by approximately $380 million or 3%, partially offset by the solid performance of key cheap azithromycin products. Reported revenues accounted for 43% of the total. This decrease was primarily attributable to
tetanus and antibiotic tetanu the negative impact antibiotic of the loss of U.S. azythromycin Reported revenues were $5.3 billion in fourth-quarter 2008, a decrease of 8% compared with the year-ago quarter.
PFE - News) today reported financial results azithromycin livestock for
- fourth-quarter zithromax and full-year 2008.
International
- reported revenues were $7.1 billion, a decrease of 1% compared what antibiotic to use for iguana bite with the year-ago quarter, and reflect operational growth of 5%, which was more
than offset by the antibiotics unfavorable impact of foreign exchange of 6%. For fourth-quarter 2008, the Company
recorded reported prescription medication revenues of $12.3 billion, a decrease azithromycin antibiotic for ear infection dogs dog of 4% compared
with the year-ago quarter. ($ tetracyclin in millions, except per share amounts) top rated online pharmacies Fourth-Quarter
antibiotic Full-Year 2008 2007 antibiotic pumps perth pump Change 2008 antibiotics 2007 Change can polysporin antibiotic eyedrops be used on the skin Reported Revenues $ 12,346 azythromycin
tetracycline $ 12,870 (4%) $ 48,296 $ 48,418 -- Reported Net Income zithromax antibiotic for tooth infection 266 2,724 (90%) 8,104 8,144 -- Reported Diluted EPS 0.04 antibiotics for viral infections 0.40 (90%) 1.20 legal buy prescription drugs online 1.17 3% Adjusted Revenues(1) 12,311 12,795 (4%) 48,341 48,209 -- Adjusted Income(1) 4,389 3,402 29% 16,366 15,113 8% Adjusted Diluted EPS(1) 0.65 0.50 30% 2.42 2.18 11% See end of text prior to tables for notes. NEW YORK-- --Pfizer Inc (NYSE.